Literature DB >> 27519214

Expression of leukemia inhibitory factor in craniopharyngioma.

A Tran1,2, K Kovacs1,2, L Stefaneanu1,2, G Kontogeorgos1,2, B W Scheithauer3, S Melmed4.   

Abstract

It has recently been reported that overexpression of leukemia inhibitory factor (LIF) in mice transgenic for LIF causes invagination of the anterior wall of Rathke's pouch leading to the formation of cysts lined by LIF immunoreactive epithelial cells. Strong immunoreactivity was also found in human Rathke's cleft cysts. Because such cysts and craniopharyngiomas share a common histogenesis, we raised the question of whether LIF is also expressed in craniopharyngioma.Fourteen histologically verified craniopharyngiomas of adamantinomatous type were examined for LIF immunoreactivity using the streptavidin-biotin-peroxidase complex method. Rabbit-anti-LIF antibody dilution 1:40) was applied to tissues having undergone antigen retrieval (microwaving in citrate buffer at pH 6). For positive control, nontumorous pituitary tissues were used. Primary antibody substituted with phosphate-buffered saline served as a negative control.By immunocytochemistry, the epithelial cells of all 14 craniopharyngiomas were LIF immunoreactive, showing varying degrees of staining intensity. In comparison, the connective tissue components of the tumors were immunonegative.Our study provides evidence that LIF is expressed in the epithelial cells of craniopharyngioma. Further investigation is required to elucidate the possible role of LIF in the development and progression of craniopharyngiomas.

Entities:  

Keywords:  Craniopharyngioma; Rathke’s cleft cyst; immunocytochemistry; leukemia inhibitory factor; pituitary

Year:  1999        PMID: 27519214     DOI: 10.1007/BF02739822

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  24 in total

Review 1.  The leukemia inhibitory factor (LIF).

Authors:  D Metcalf
Journal:  Int J Cell Cloning       Date:  1991-03

Review 2.  The role of cytokines in the normal and neoplastic pituitary.

Authors:  S Tsagarakis; G Kontogeorgos; K Kovacs
Journal:  Crit Rev Oncol Hematol       Date:  1998-08       Impact factor: 6.312

3.  Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response.

Authors:  V Chesnokova; C J Auernhammer; S Melmed
Journal:  Endocrinology       Date:  1998-05       Impact factor: 4.736

4.  Leukemia inhibitory factor modulates interleukin-1beta-induced activation of the hypothalamo-pituitary-adrenal axis.

Authors:  C J Auernhammer; V Chesnokova; S Melmed
Journal:  Endocrinology       Date:  1998-05       Impact factor: 4.736

Review 5.  Leukemia inhibitory factor: part of a large ingathering family.

Authors:  J L Taupin; V Pitard; J Dechanet; V Miossec; N Gualde; J F Moreau
Journal:  Int Rev Immunol       Date:  1998       Impact factor: 5.311

6.  Clonal analysis of the action of GM-CSF on the proliferation and differentiation of myelomonocytic leukemic cells.

Authors:  D Metcalf
Journal:  Int J Cancer       Date:  1979-11-15       Impact factor: 7.396

7.  Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: identification as leukemia inhibitory factor.

Authors:  N Ferrara; J Winer; W J Henzel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

8.  Leukemia-inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways.

Authors:  P Kellokumpu-Lehtinen; M Talpaz; D Harris; Q Van; R Kurzrock; Z Estrov
Journal:  Int J Cancer       Date:  1996-05-16       Impact factor: 7.396

9.  Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion.

Authors:  S Akita; J Webster; S G Ren; H Takino; J Said; O Zand; S Melmed
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

10.  Cytokine production in five tumor cell lines with activity to induce cancer cachexia syndrome in nude mice.

Authors:  H Iseki; N Kajimura; C Ohue; R Tanaka; Y Akiyama; K Yamaguchi
Journal:  Jpn J Cancer Res       Date:  1995-06
View more
  2 in total

1.  Rathke's cleft-like cysts arise from Isl1 deletion in murine pituitary progenitors.

Authors:  Michelle L Brinkmeier; Hironori Bando; Adriana C Camarano; Shingo Fujio; Koji Yoshimoto; Flávio Sj de Souza; Sally A Camper
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

2.  Expression of leukemia inhibitory factor in human pituitary adenomas: a morphologic and immunocytochemical study.

Authors:  G Kontogeorgos; H Patralexis; A Tran; K Kovacs; S Melmed
Journal:  Pituitary       Date:  2000-05       Impact factor: 4.107

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.